Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome

NCT00169637 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: rhGH

Sponsor

Hospices Civils de Lyon